Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Aging & Longevity

Inside Equinox’s Elite $40,000 Longevity Program: What You Need to Know

by Team Lumida
May 17, 2024
in Aging & Longevity, Health and Longevity, Lifestyle, Themes
Reading Time: 3 mins read
A A
0
woman wearing black sports bra

Photo by Scott Webb on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Equinox offers a $40,000 annual personalized wellness program.
  2. Program includes extensive lab tests, personal training, and wellness coaching.
  3. Focus on longevity aligns with global wellness trends.

What Happened?

Equinox introduced Optimize by Equinox, a personalized wellness program costing $40,000 per year. Launching in New York and Texas, the program aims to help members enhance their longevity and overall health. Members receive in-depth assessments, lab tests, personal training sessions, nutritional coaching, sleep coaching, and more.

The initiative is a partnership with Function Health, co-founded by Dr. Mark Hyman. Equinox’s program reflects a growing trend in the wellness industry, where high-end fitness centers evolve into comprehensive health and longevity clinics.

Why It Matters?

Why should you care about Equinox’s new program? The wellness industry is booming, and Equinox’s move to offer a $40,000 personalized program highlights the increasing demand for comprehensive health and longevity solutions. This shift could attract high-net-worth individuals seeking top-tier health services, potentially boosting Equinox’s revenue and market position.

Moreover, the partnership with Function Health underscores the value of integrating advanced medical diagnostics with fitness. This trend could drive innovation and competition in the wellness market, offering investors new opportunities.

What’s Next?

So, what’s next for Equinox and the wellness industry? Equinox plans to expand the program to more markets throughout the year, potentially increasing its membership and market share. As the demand for longevity and preventive health services grows, expect more fitness brands to adopt similar models.

Investors should watch for further developments in the wellness sector, particularly those involving partnerships with medical and diagnostic companies. Equinox’s success could signal a broader industry shift, emphasizing the importance of holistic health and personalized wellness programs in the future.

Previous Post

The Truth About Full-Body MRIs: A $2,500 Investment in Your Health?

Next Post

Xpeng Charges Into Hong Kong with New EV Models

Recommended For You

Ares Recovers About Half of Roughly £1 Billion in TalkTalk Despite Climbing to the Top of the Capital Structure

by Team Lumida
59 minutes ago
Ares Recovers About Half of Roughly £1 Billion in TalkTalk Despite Climbing to the Top of the Capital Structure

Each successive injection ranked higher than the last, ending in a super senior facility first in line. It still lost half.

Read more

Dimon Says AI Cyber Risk Rose Tenfold After Mythos, While Declining to Engage With the Existential Question

by Team Lumida
1 hour ago
Dimon Says AI Cyber Risk Rose Tenfold After Mythos, While Declining to Engage With the Existential Question

The largest US bank now frames AI as a controls problem to be engineered around rather than a civilisational one.

Read more

Arbitrum Backs Paxos USDG to Capture Reserve Income From the $3.8 Billion of Stablecoins Already on Its Network

by Team Lumida
1 hour ago
Arbitrum Backs Paxos USDG to Capture Reserve Income From the $3.8 Billion of Stablecoins Already on Its Network

Circle's USDC is 60% of that balance and Arbitrum earns nothing from it. Consortium models are redistributing issuer economics to distributors.

Read more

Anthropic’s IPO Smoke Screen — $518 Billion in Compute Commitments Hidden Behind Existential Risk Disclosure as Prospectus Fails to Disclose True Shareholder Structure

by Team Lumida
6 hours ago
Anthropic Tells Investors It Will Post a Second Straight Profitable Quarter Ahead of Nasdaq IPO

Anthropic IPO prospectus warns existential risks to humanity (not HAL 9000—shareholder lawsuit protection). Public-benefit corp allows profit sacrifice for safety. $518B compute commitments ($414B noncancelable). Tangible assets rounding...

Read more

AI Leaders Face the Bill — Altman and Amodei Now in Crosshairs as Insurers Brace for Executive Liability Claims Over Rogue Agents

by Team Lumida
7 hours ago
AI Startups Rush to Sell: Hugging Face CEO Shares Insights

Rogue AI agents (Hugging Face hack) breaking controls trigger D&O insurance exposure for executives. Altman/Amodei liability risk tested. Aon analyzed 300+ AI legal cases. D&O policies, crime, cyber,...

Read more

Stripe Takes Stablecoin Cards to 100+ Countries While Funding a Rival to the USDC Its Programmes Run On

by Team Lumida
1 day ago
Stripe Takes Stablecoin Cards to 100+ Countries While Funding a Rival to the USDC Its Programmes Run On

Monthly stablecoin card spending has tripled to $1.2 billion, which is rapid growth against a negligible base.

Read more

TRex Bio Seeks $133 Million at a $439 Million Valuation With Lilly Buying In Right Up to the 19.9% Threshold

by Team Lumida
1 day ago
Iambic Therapeutics Files for IPO; Nvidia-Backed AI Drug Discovery Firm Targeting Cancer Treatments; Partners With Abbvie, Takeda; Ticker IAM

Three of the largest pharmaceutical companies sit on the cap table, and the entire valuation rests on one readout due in mid-2027.

Read more

SEC Clears 3x Bitcoin and Ether ETFs as Implied Volatility Sits at 35% to 40%, the Exact Condition That Erodes Them

by Team Lumida
1 day ago
SEC Clears 3x Bitcoin and Ether ETFs as Implied Volatility Sits at 35% to 40%, the Exact Condition That Erodes Them

The issuer's own prospectus says the product is speculative and should only be held by investors who can bear total loss.

Read more

Strategy Books a $21 Billion Unrealized Gain, Which Mostly Recovers an Underwater Position Rather Than Creating Profit

by Team Lumida
1 day ago
Strategy Books a $21 Billion Unrealized Gain, Which Mostly Recovers an Underwater Position Rather Than Creating Profit

The company spent $176 million buying back preferred shares in four days against $28.7 million of bitcoin.

Read more

The AI Capex Machine Keeps Roaring — Nvidia’s Manufacturing Partner Hon Hai Crushes Estimates as Server Demand Drowns Out Recession Fears

by Team Lumida
1 day ago
The AI Capex Machine Keeps Roaring — Nvidia’s Manufacturing Partner Hon Hai Crushes Estimates as Server Demand Drowns Out Recession Fears

Hon Hai Q3 sales NT$3.03T ($95.4B), up 47% YoY (beat NT$2.83T estimate). Nvidia server assembly partner. Micron also beat last week (AI spending validation). Cloud now largest segment....

Read more
Next Post
Solar Charging Station in the Parking Lot

Xpeng Charges Into Hong Kong with New EV Models

a view of a city with a lake and mountains in the background

China Unleashes $42B Rescue to Save Crumbling Property Sector

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a computer chip with the letter ai on it

Grid Tech Startups Surge as AI Data Centers Drive Power Demand Revolution

January 28, 2025
woman in purple polo shirt wearing eyeglasses

Retirement Health Worries: Navigating Dementia and Heart Risks in the Golden Years

March 10, 2025
app, apple, hand

Uber Q2 2024 Earnings Highlights: Strong Growth With Record Profitability

August 7, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018